カテゴリー： LP Information, 世界, 医療/バイオ

世界の糖尿病性眼疾患用装置市場予測 2021年-2026年

【英語タイトル】Global Diabetic Eye Disease Devices Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY8906）・商品コード：LPI21MY8906
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：159
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療装置
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「糖尿病性眼疾患用装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、レーザー手術、硝子体切除術など、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。糖尿病性眼疾患用装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・糖尿病性眼疾患用装置の世界市場概要（サマリー）
・糖尿病性眼疾患用装置の企業別販売量・売上
・糖尿病性眼疾患用装置の企業別市場シェア
・糖尿病性眼疾患用装置の世界市場規模 2016年-2021年：種類別（レーザー手術、硝子体切除術）
・糖尿病性眼疾患用装置の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他）
・糖尿病性眼疾患用装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・糖尿病性眼疾患用装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・糖尿病性眼疾患用装置のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・糖尿病性眼疾患用装置の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・糖尿病性眼疾患用装置市場の成長要因・課題・動向
・糖尿病性眼疾患用装置の世界市場予測 2021年-2026年
・糖尿病性眼疾患用装置の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・糖尿病性眼疾患用装置のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・糖尿病性眼疾患用装置のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・糖尿病性眼疾患用装置の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・糖尿病性眼疾患用装置の世界市場予測：種類別（レーザー手術、硝子体切除術）
・糖尿病性眼疾患用装置の世界市場予測：用途別（病院、クリニック、その他）
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Diabetic Eye Disease Devices will have significant change from previous year. By the most conservative estimates of global Diabetic Eye Disease Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Diabetic Eye Disease Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Eye Disease Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Laser Surgery
Vitrectomy

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospitals
Clinics
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
IRIDEX
Ellex
Alcon
Bausch & Lomb
Synergetics USA
Topcon
Carl Zeiss Meditec
Johnson & Johnson
NIDEK
Quantel
Rhein Medical
Lumenis
Meridian

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diabetic Eye Disease Devices Consumption 2016-2026
2.1.2 Diabetic Eye Disease Devices Consumption CAGR by Region
2.2 Diabetic Eye Disease Devices Segment by Type
2.2.1 Laser Surgery
2.2.2 Vitrectomy
2.3 Diabetic Eye Disease Devices Sales by Type
2.3.1 Global Diabetic Eye Disease Devices Sales Market Share by Type (2016-2021)
2.3.2 Global Diabetic Eye Disease Devices Revenue and Market Share by Type (2016-2021)
2.3.3 Global Diabetic Eye Disease Devices Sale Price by Type (2016-2021)
2.4 Diabetic Eye Disease Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Diabetic Eye Disease Devices Sales by Application
2.5.1 Global Diabetic Eye Disease Devices Sale Market Share by Application (2016-2021)
2.5.2 Global Diabetic Eye Disease Devices Revenue and Market Share by Application (2016-2021)
2.5.3 Global Diabetic Eye Disease Devices Sale Price by Application (2016-2021)

3 Global Diabetic Eye Disease Devices by Company
3.1 Global Diabetic Eye Disease Devices Sales Market Share by Company
3.1.1 Global Diabetic Eye Disease Devices Sales by Company (2019-2021)
3.1.2 Global Diabetic Eye Disease Devices Sales Market Share by Company (2019-2021)
3.2 Global Diabetic Eye Disease Devices Revenue Market Share by Company
3.2.1 Global Diabetic Eye Disease Devices Revenue by Company (2019-2021)
3.2.2 Global Diabetic Eye Disease Devices Revenue Market Share by Company (2019-2021)
3.3 Global Diabetic Eye Disease Devices Sale Price by Company
3.4 Global Manufacturers Diabetic Eye Disease Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Diabetic Eye Disease Devices Product Location Distribution
3.4.2 Players Diabetic Eye Disease Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Diabetic Eye Disease Devices by Region
4.1 Global Diabetic Eye Disease Devices by Region
4.1.1 Global Diabetic Eye Disease Devices Sales by Region
4.1.2 Global Diabetic Eye Disease Devices Revenue by Region
4.2 Americas Diabetic Eye Disease Devices Sales Growth
4.3 APAC Diabetic Eye Disease Devices Sales Growth
4.4 Europe Diabetic Eye Disease Devices Sales Growth
4.5 Middle East & Africa Diabetic Eye Disease Devices Sales Growth

5 Americas
5.1 Americas Diabetic Eye Disease Devices Sales by Country
5.1.1 Americas Diabetic Eye Disease Devices Sales by Country (2016-2021)
5.1.2 Americas Diabetic Eye Disease Devices Revenue by Country (2016-2021)
5.2 Americas Diabetic Eye Disease Devices Sales by Type
5.3 Americas Diabetic Eye Disease Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Diabetic Eye Disease Devices Sales by Region
6.1.1 APAC Diabetic Eye Disease Devices Sales by Region (2016-2021)
6.1.2 APAC Diabetic Eye Disease Devices Revenue by Region (2016-2021)
6.2 APAC Diabetic Eye Disease Devices Sales by Type
6.3 APAC Diabetic Eye Disease Devices Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Diabetic Eye Disease Devices by Country
7.1.1 Europe Diabetic Eye Disease Devices Sales by Country (2016-2021)
7.1.2 Europe Diabetic Eye Disease Devices Revenue by Country (2016-2021)
7.2 Europe Diabetic Eye Disease Devices Sales by Type
7.3 Europe Diabetic Eye Disease Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Diabetic Eye Disease Devices by Country
8.1.1 Middle East & Africa Diabetic Eye Disease Devices Sales by Country (2016-2021)
8.1.2 Middle East & Africa Diabetic Eye Disease Devices Revenue by Country (2016-2021)
8.2 Middle East & Africa Diabetic Eye Disease Devices Sales by Type
8.3 Middle East & Africa Diabetic Eye Disease Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Diabetic Eye Disease Devices Distributors
10.3 Diabetic Eye Disease Devices Customer

11 Global Diabetic Eye Disease Devices Market Forecast
11.1 Global Diabetic Eye Disease Devices Forecast by Region
11.1.1 Global Diabetic Eye Disease Devices Forecast by Regions (2021-2026)
11.2.2 Global Diabetic Eye Disease Devices Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Diabetic Eye Disease Devices Forecast by Type
11.7 Global Diabetic Eye Disease Devices Forecast by Application

12 Key Players Analysis
12.1 IRIDEX
12.1.1 IRIDEX IRIDEX Company Information
12.1.2 IRIDEX Diabetic Eye Disease Devices Product Offered
12.1.3 IRIDEX Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 IRIDEX Main Business Overview
12.1.5 IRIDEX Latest Developments
12.2 Ellex
12.2.1 Ellex Company Information
12.2.2 Ellex Diabetic Eye Disease Devices Product Offered
12.2.3 Ellex Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Ellex Main Business Overview
12.2.5 Ellex Latest Developments
12.3 Alcon
12.3.1 Alcon Company Information
12.3.2 Alcon Diabetic Eye Disease Devices Product Offered
12.3.3 Alcon Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Alcon Main Business Overview
12.3.5 Alcon Latest Developments
12.4 Bausch & Lomb
12.4.1 Bausch & Lomb Company Information
12.4.2 Bausch & Lomb Diabetic Eye Disease Devices Product Offered
12.4.3 Bausch & Lomb Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Bausch & Lomb Main Business Overview
12.4.5 Bausch & Lomb Latest Developments
12.5 Synergetics USA
12.5.1 Synergetics USA Company Information
12.5.2 Synergetics USA Diabetic Eye Disease Devices Product Offered
12.5.3 Synergetics USA Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Synergetics USA Main Business Overview
12.5.5 Synergetics USA Latest Developments
12.6 Topcon
12.6.1 Topcon Company Information
12.6.2 Topcon Diabetic Eye Disease Devices Product Offered
12.6.3 Topcon Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Topcon Main Business Overview
12.6.5 Topcon Latest Developments
12.7 Carl Zeiss Meditec
12.7.1 Carl Zeiss Meditec Company Information
12.7.2 Carl Zeiss Meditec Diabetic Eye Disease Devices Product Offered
12.7.3 Carl Zeiss Meditec Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Carl Zeiss Meditec Main Business Overview
12.7.5 Carl Zeiss Meditec Latest Developments
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Information
12.8.2 Johnson & Johnson Diabetic Eye Disease Devices Product Offered
12.8.3 Johnson & Johnson Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Johnson & Johnson Main Business Overview
12.8.5 Johnson & Johnson Latest Developments
12.9 NIDEK
12.9.1 NIDEK Company Information
12.9.2 NIDEK Diabetic Eye Disease Devices Product Offered
12.9.3 NIDEK Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 NIDEK Main Business Overview
12.9.5 NIDEK Latest Developments
12.10 Quantel
12.10.1 Quantel Company Information
12.10.2 Quantel Diabetic Eye Disease Devices Product Offered
12.10.3 Quantel Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Quantel Main Business Overview
12.10.5 Quantel Latest Developments
12.11 Rhein Medical
12.11.1 Rhein Medical Company Information
12.11.2 Rhein Medical Diabetic Eye Disease Devices Product Offered
12.11.3 Rhein Medical Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Rhein Medical Main Business Overview
12.11.5 Rhein Medical Latest Developments
12.12 Lumenis
12.12.1 Lumenis Company Information
12.12.2 Lumenis Diabetic Eye Disease Devices Product Offered
12.12.3 Lumenis Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Lumenis Main Business Overview
12.12.5 Lumenis Latest Developments
12.13 Meridian
12.13.1 Meridian Company Information
12.13.2 Meridian Diabetic Eye Disease Devices Product Offered
12.13.3 Meridian Diabetic Eye Disease Devices Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Meridian Main Business Overview
12.13.5 Meridian Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Diabetic Eye Disease Devices Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Laser Surgery
Table 3. Major Players of Vitrectomy
Table 4. Global Diabetic Eye Disease Devices Sales by Type (2016-2021) & (K Units)
Table 5. Global Diabetic Eye Disease Devices Sales Market Share by Type (2016-2021)
Table 6. Global Diabetic Eye Disease Devices Revenue by Type (2016-2021) & ($ million)
Table 7. Global Diabetic Eye Disease Devices Revenue Market Share by Type (2016-2021)
Table 8. Global Diabetic Eye Disease Devices Sale Price by Type (2016-2021)
Table 9. Global Diabetic Eye Disease Devices Sales by Application (2016-2021) & (K Units)
Table 10. Global Diabetic Eye Disease Devices Sales Market Share by Application (2016-2021)
Table 11. Global Diabetic Eye Disease Devices Value by Application (2016-2021)
Table 12. Global Diabetic Eye Disease Devices Revenue Market Share by Application (2016-2021)
Table 13. Global Diabetic Eye Disease Devices Sale Price by Application (2016-2021)
Table 14. Global Diabetic Eye Disease Devices Sales by Company (2019-2021) & (K Units)
Table 15. Global Diabetic Eye Disease Devices Sales Market Share by Company (2019-2021)
Table 16. Global Diabetic Eye Disease Devices Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Diabetic Eye Disease Devices Revenue Market Share by Company (2019-2021)
Table 18. Global Diabetic Eye Disease Devices Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Diabetic Eye Disease Devices Producing Area Distribution and Sales Area
Table 20. Players Diabetic Eye Disease Devices Products Offered
Table 21. Diabetic Eye Disease Devices Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Diabetic Eye Disease Devices Sales by Region (2016-2021) (K Units)
Table 25. Global Diabetic Eye Disease Devices Sales Market Share by Region (2016-2021)
Table 26. Global Diabetic Eye Disease Devices Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Diabetic Eye Disease Devices Revenue Market Share by Region (2016-2021)
Table 28. Americas Diabetic Eye Disease Devices Sales by Country (2016-2021) & (K Units)
Table 29. Americas Diabetic Eye Disease Devices Sales Market Share by Country (2016-2021)
Table 30. Americas Diabetic Eye Disease Devices Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Diabetic Eye Disease Devices Revenue Market Share by Country (2016-2021)
Table 32. Americas Diabetic Eye Disease Devices Sales by Type (2016-2021) & (K Units)
Table 33. Americas Diabetic Eye Disease Devices Sales Market Share by Type (2016-2021)
Table 34. Americas Diabetic Eye Disease Devices Sales by Application (2016-2021) & (K Units)
Table 35. Americas Diabetic Eye Disease Devices Sales Market Share by Application (2016-2021)
Table 36. APAC Diabetic Eye Disease Devices Sales by Region (2016-2021) & (K Units)
Table 37. APAC Diabetic Eye Disease Devices Sales Market Share by Region (2016-2021)
Table 38. APAC Diabetic Eye Disease Devices Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Diabetic Eye Disease Devices Revenue Market Share by Region (2016-2021)
Table 40. APAC Diabetic Eye Disease Devices Sales by Type (2016-2021) & (K Units)
Table 41. APAC Diabetic Eye Disease Devices Sales Market Share by Type (2016-2021)
Table 42. APAC Diabetic Eye Disease Devices Sales by Application (2016-2021) & (K Units)
Table 43. APAC Diabetic Eye Disease Devices Sales Market Share by Application (2016-2021)
Table 44. Europe Diabetic Eye Disease Devices Sales by Country (2016-2021) & (K Units)
Table 45. Europe Diabetic Eye Disease Devices Sales Market Share by Country (2016-2021)
Table 46. Europe Diabetic Eye Disease Devices Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Diabetic Eye Disease Devices Revenue Market Share by Country (2016-2021)
Table 48. Europe Diabetic Eye Disease Devices Sales by Type (2016-2021) & (K Units)
Table 49. Europe Diabetic Eye Disease Devices Sales Market Share by Type (2016-2021)
Table 50. Europe Diabetic Eye Disease Devices Sales by Application (2016-2021) & (K Units)
Table 51. Europe Diabetic Eye Disease Devices Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Diabetic Eye Disease Devices Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Diabetic Eye Disease Devices Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Diabetic Eye Disease Devices Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Diabetic Eye Disease Devices Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Diabetic Eye Disease Devices Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Diabetic Eye Disease Devices Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Diabetic Eye Disease Devices Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Diabetic Eye Disease Devices Sales Market Share by Application (2016-2021)
Table 60. Global Diabetic Eye Disease Devices Sales Forecast by Type (2021-2026) & (K Units)
Table 61. Global Diabetic Eye Disease Devices Sales Market Share Forecast by Type (2021-2026)
Table 62. Global Diabetic Eye Disease Devices Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 63. Global Diabetic Eye Disease Devices Revenue Market Share Forecast by Type (2021-2026)
Table 64. Global Diabetic Eye Disease Devices Sales Forecast by Application (2021-2026) & (K Units)
Table 65. Global Diabetic Eye Disease Devices Sales Market Share Forecast by Application (2021-2026)
Table 66. Global Diabetic Eye Disease Devices Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 67. Global Diabetic Eye Disease Devices Revenue Market Share Forecast by Application (2021-2026)
Table 68. IRIDEX Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 69. IRIDEX Diabetic Eye Disease Devices Product Offered
Table 70. IRIDEX Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 71. IRIDEX Main Business
Table 72. IRIDEX Latest Developments
Table 73. Ellex Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 74. Ellex Diabetic Eye Disease Devices Product Offered
Table 75. Ellex Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 76. Ellex Main Business
Table 77. Ellex Latest Developments
Table 78. Alcon Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Alcon Diabetic Eye Disease Devices Product Offered
Table 80. Alcon Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 81. Alcon Main Business
Table 82. Alcon Latest Developments
Table 83. Bausch & Lomb Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Bausch & Lomb Diabetic Eye Disease Devices Product Offered
Table 85. Bausch & Lomb Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 86. Bausch & Lomb Main Business
Table 87. Bausch & Lomb Latest Developments
Table 88. Synergetics USA Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Synergetics USA Diabetic Eye Disease Devices Product Offered
Table 90. Synergetics USA Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Synergetics USA Main Business
Table 92. Synergetics USA Latest Developments
Table 93. Topcon Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. Topcon Diabetic Eye Disease Devices Product Offered
Table 95. Topcon Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Topcon Main Business
Table 97. Topcon Latest Developments
Table 98. Carl Zeiss Meditec Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. Carl Zeiss Meditec Diabetic Eye Disease Devices Product Offered
Table 100. Carl Zeiss Meditec Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. Carl Zeiss Meditec Main Business
Table 102. Carl Zeiss Meditec Latest Developments
Table 103. Johnson & Johnson Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. Johnson & Johnson Diabetic Eye Disease Devices Product Offered
Table 105. Johnson & Johnson Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Johnson & Johnson Main Business
Table 107. Johnson & Johnson Latest Developments
Table 108. NIDEK Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 109. NIDEK Diabetic Eye Disease Devices Product Offered
Table 110. NIDEK Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. NIDEK Main Business
Table 112. NIDEK Latest Developments
Table 113. Quantel Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 114. Quantel Diabetic Eye Disease Devices Product Offered
Table 115. Quantel Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. Quantel Main Business
Table 117. Quantel Latest Developments
Table 118. Rhein Medical Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 119. Rhein Medical Diabetic Eye Disease Devices Product Offered
Table 120. Rhein Medical Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Rhein Medical Main Business
Table 122. Rhein Medical Latest Developments
Table 123. Lumenis Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 124. Lumenis Diabetic Eye Disease Devices Product Offered
Table 125. Lumenis Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. Lumenis Main Business
Table 127. Lumenis Latest Developments
Table 128. Meridian Basic Information, Diabetic Eye Disease Devices Manufacturing Base, Sales Area and Its Competitors
Table 129. Meridian Diabetic Eye Disease Devices Product Offered
Table 130. Meridian Diabetic Eye Disease Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. Meridian Main Business
Table 132. Meridian Latest Developments
List of Figures
Figure 1. Picture of Diabetic Eye Disease Devices
Figure 2. Diabetic Eye Disease Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diabetic Eye Disease Devices Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Diabetic Eye Disease Devices Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Diabetic Eye Disease Devices Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Laser Surgery
Figure 10. Product Picture of Vitrectomy
Figure 11. Global Diabetic Eye Disease Devices Sales Market Share by Type in 2020
Figure 12. Global Diabetic Eye Disease Devices Revenue Market Share by Type (2016-2021)
Figure 13. Diabetic Eye Disease Devices Consumed in Hospitals
Figure 14. Global Diabetic Eye Disease Devices Market: Hospitals (2016-2021) & (K Units)
Figure 15. Diabetic Eye Disease Devices Consumed in Clinics
Figure 16. Global Diabetic Eye Disease Devices Market: Clinics (2016-2021) & (K Units)
Figure 17. Diabetic Eye Disease Devices Consumed in Other
Figure 18. Global Diabetic Eye Disease Devices Market: Other (2016-2021) & (K Units)
Figure 19. Global Diabetic Eye Disease Devices Sales Market Share by Application (2016-2021)
Figure 20. Global Diabetic Eye Disease Devices Revenue Market Share by Application in 2020
Figure 21. Global Diabetic Eye Disease Devices Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Diabetic Eye Disease Devices Revenue Market Share by Company in 2020
Figure 23. Global Diabetic Eye Disease Devices Sales Market Share by Regions (2016-2021)
Figure 24. Global Diabetic Eye Disease Devices Revenue Market Share by Region in 2020
Figure 25. Americas Diabetic Eye Disease Devices Sales 2016-2021 (K Units)
Figure 26. Americas Diabetic Eye Disease Devices Revenue 2016-2021 ($ Millions)
Figure 27. APAC Diabetic Eye Disease Devices Sales 2016-2021 (K Units)
Figure 28. APAC Diabetic Eye Disease Devices Revenue 2016-2021 ($ Millions)
Figure 29. Europe Diabetic Eye Disease Devices Sales 2016-2021 (K Units)
Figure 30. Europe Diabetic Eye Disease Devices Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Diabetic Eye Disease Devices Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Diabetic Eye Disease Devices Revenue 2016-2021 ($ Millions)
Figure 33. Americas Diabetic Eye Disease Devices Sales Market Share by Country in 2020
Figure 34. Americas Diabetic Eye Disease Devices Revenue Market Share by Country in 2020
Figure 35. Americas Diabetic Eye Disease Devices Sales Market Share by Type in 2020
Figure 36. Americas Diabetic Eye Disease Devices Sales Market Share by Application in 2020
Figure 37. United States Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Diabetic Eye Disease Devices Sales Market Share by Region in 2020
Figure 42. APAC Diabetic Eye Disease Devices Revenue Market Share by Regions in 2020
Figure 43. APAC Diabetic Eye Disease Devices Sales Market Share by Type in 2020
Figure 44. APAC Diabetic Eye Disease Devices Sales Market Share by Application in 2020
Figure 45. China Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Diabetic Eye Disease Devices Sales Market Share by Country in 2020
Figure 52. Europe Diabetic Eye Disease Devices Revenue Market Share by Country in 2020
Figure 53. Europe Diabetic Eye Disease Devices Sales Market Share by Type in 2020
Figure 54. Europe Diabetic Eye Disease Devices Sales Market Share by Application in 2020
Figure 55. Germany Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Diabetic Eye Disease Devices Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Diabetic Eye Disease Devices Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Diabetic Eye Disease Devices Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Diabetic Eye Disease Devices Sales Market Share by Application in 2020
Figure 64. Egypt Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Diabetic Eye Disease Devices Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles


★調査レポート[世界の糖尿病性眼疾患用装置市場予測 2021年-2026年] (コード：LPI21MY8906)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の糖尿病性眼疾患用装置市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の糖尿病用食品市場予測 2021年-2026年
    LPI21MY5393 / LP Information / 2021年5月 / LPインフォメーション社の「糖尿病用食品の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、製菓、アイスクリーム・ゼリー、ダイエット飲料、スナック、焼き菓子、乳製品、その他など、用途別には、オンライン販売、オフライン販売などにセグメント区分してまとめました。糖尿病用食品のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・糖尿病用食品の世界市場概要（サマリー） ・糖尿病用食品の企業別販売量・売上 ・糖尿病用食品の企業別市場シェア ・糖尿病用食品の世界市場規模 2016年-2021年：種類別（製菓、アイスクリーム・ゼリー、ダイエット飲料、スナック、焼き菓子、乳製品、その他） ・糖尿病用食品の世界市場規模 2016年-2021年：用途別（オンライン販売、オフライン販売） ・糖尿病用食品の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・糖尿病用食品のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Diabetic Food Products will have significant change from previous year. By the most conservative estimates of global Diabetic Food Products market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Diabetic Food Products market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Food Products market by product type,...
  • 世界の糖尿病用靴市場予測 2021年-2026年
    LPI21MY3435 / LP Information / 2021年5月 / LPインフォメーション社の「糖尿病用靴の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、靴、サンダル、スリッパなど、用途別には、オンラインプラットフォーム、専門店、靴店、その他などにセグメント区分してまとめました。糖尿病用靴のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・糖尿病用靴の世界市場概要（サマリー） ・糖尿病用靴の企業別販売量・売上 ・糖尿病用靴の企業別市場シェア ・糖尿病用靴の世界市場規模 2016年-2021年：種類別（靴、サンダル、スリッパ） ・糖尿病用靴の世界市場規模 2016年-2021年：用途別（オンラインプラットフォーム、専門店、靴店、その他） ・糖尿病用靴の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・糖尿病用靴のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Diabetic Footwear will have significant change from previous year. By the most conservative estimates of global Diabetic Footwear market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 5071.8 million in 2019. Over the next five years the Diabetic Footwear market will register a 6.4% CAGR in terms of revenue, the global market size will reach US$ 6496.8 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Footwear market by product type, application, key manufacturers and...
  • 世界のハンセン病治療薬市場予測 2021年-2026年
    LPI21MY9549 / LP Information / 2021年5月 / LPインフォメーション社の「ハンセン病治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、クロファジミン、サリドマイド、その他など、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。ハンセン病治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ハンセン病治療薬の世界市場概要（サマリー） ・ハンセン病治療薬の企業別販売量・売上 ・ハンセン病治療薬の企業別市場シェア ・ハンセン病治療薬の世界市場規模 2016年-2021年：種類別（クロファジミン、サリドマイド、その他） ・ハンセン病治療薬の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・ハンセン病治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ハンセン病治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Hansen's Disease Therapeutics will have significant change from previous year. By the most conservative estimates of global Hansen's Disease Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hansen's Disease Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Hansen's Disease Therapeutics market by product type,...
  • 世界のゴーシェ病治療薬市場予測 2021年-2026年
    LPI21MY9538 / LP Information / 2021年5月 / LPインフォメーション社の「ゴーシェ病治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、酵素、グルコシルセラミドシンターゼ阻害剤、骨粗鬆症治療薬など、用途別には、I型ゴーシェ病、II型ゴーシェ病、III型ゴーシェ病などにセグメント区分してまとめました。ゴーシェ病治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ゴーシェ病治療薬の世界市場概要（サマリー） ・ゴーシェ病治療薬の企業別販売量・売上 ・ゴーシェ病治療薬の企業別市場シェア ・ゴーシェ病治療薬の世界市場規模 2016年-2021年：種類別（酵素、グルコシルセラミドシンターゼ阻害剤、骨粗鬆症治療薬） ・ゴーシェ病治療薬の世界市場規模 2016年-2021年：用途別（I型ゴーシェ病、II型ゴーシェ病、III型ゴーシェ病） ・ゴーシェ病治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ゴーシェ病治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Gaucher Disease Drugs will have significant change from previous year. By the most conservative estimates of global Gaucher Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1292.3 million in 2019. Over the next five years the Gaucher Disease Drugs market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 1326.1 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Gaucher Disease Drugs market by product type,...
  • 世界の心血管疾患治療薬市場予測 2021年-2026年
    LPI21MY9466 / LP Information / 2021年5月 / LPインフォメーション社の「心血管疾患治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他など、用途別には、虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他などにセグメント区分してまとめました。心血管疾患治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管疾患治療薬の世界市場概要（サマリー） ・心血管疾患治療薬の企業別販売量・売上 ・心血管疾患治療薬の企業別市場シェア ・心血管疾患治療薬の世界市場規模 2016年-2021年：種類別（ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他） ・心血管疾患治療薬の世界市場規模 2016年-2021年：用途別（虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他） ・心血管疾患治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管疾患治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Disease Drugs will have significant change from previous year. By the most conservative estimates of global Cardiovascular Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cardiovascular Disease Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Disease Drugs market by product type,...
  • 世界の疾病検査用口腔液収集チューブ市場予測 2021年-2026年
    LPI21MY9167 / LP Information / 2021年5月 / LPインフォメーション社の「疾病検査用口腔液収集チューブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、唾液チューブ、口腔スポンジなど、用途別には、一般分析用、ゲノム分析用などにセグメント区分してまとめました。疾病検査用口腔液収集チューブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・疾病検査用口腔液収集チューブの世界市場概要（サマリー） ・疾病検査用口腔液収集チューブの企業別販売量・売上 ・疾病検査用口腔液収集チューブの企業別市場シェア ・疾病検査用口腔液収集チューブの世界市場規模 2016年-2021年：種類別（唾液チューブ、口腔スポンジ） ・疾病検査用口腔液収集チューブの世界市場規模 2016年-2021年：用途別（一般分析用、ゲノム分析用） ・疾病検査用口腔液収集チューブの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・疾病検査用口腔液収集チューブのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Oral Fluid Collection Tubes for Disease Testing will have significant change from previous year. By the most conservative estimates of global Oral Fluid Collection Tubes for Disease Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Oral Fluid Collection Tubes for Disease Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market...
  • 世界のMRD（最小残存病変）検査市場予測 2021年-2026年
    LPI21MY9126 / LP Information / 2021年5月 / LPインフォメーション社の「MRD（最小残存病変）検査の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）など、用途別には、専門クリニック・病院、診断研究所、研究機関などにセグメント区分してまとめました。MRD（最小残存病変）検査のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・MRD（最小残存病変）検査の世界市場概要（サマリー） ・MRD（最小残存病変）検査の企業別販売量・売上 ・MRD（最小残存病変）検査の企業別市場シェア ・MRD（最小残存病変）検査の世界市場規模 2016年-2021年：種類別（フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）） ・MRD（最小残存病変）検査の世界市場規模 2016年-2021年：用途別（専門クリニック・病院、診断研究所、研究機関） ・MRD（最小残存病変）検査の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・MRD（最小残存病変）検査のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of MRD (Minimal Residual Disease) Testing will have significant change from previous year. By the most conservative estimates of global MRD (Minimal Residual Disease) Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the MRD (Minimal Residual Disease) Testing market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of MRD...
  • 世界の希少疾患治療薬市場予測 2021年-2026年
    LPI21MY9563 / LP Information / 2021年5月 / LPインフォメーション社の「希少疾患治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、1‰以上、0.65‰〜1‰、0.1‰以下など、用途別には、病院薬局、専門薬局、小売薬局、その他などにセグメント区分してまとめました。希少疾患治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・希少疾患治療薬の世界市場概要（サマリー） ・希少疾患治療薬の企業別販売量・売上 ・希少疾患治療薬の企業別市場シェア ・希少疾患治療薬の世界市場規模 2016年-2021年：種類別（1‰以上、0.65‰〜1‰、0.1‰以下） ・希少疾患治療薬の世界市場規模 2016年-2021年：用途別（病院薬局、専門薬局、小売薬局、その他） ・希少疾患治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・希少疾患治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Rare Disease Drug will have significant change from previous year. By the most conservative estimates of global Rare Disease Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Rare Disease Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Rare Disease Drug market by product type,...
  • 世界の侵襲性真菌症（IFD）感染診断試薬市場予測 2021年-2026年
    LPI21MY9649 / LP Information / 2021年5月 / LPインフォメーション社の「侵襲性真菌症（IFD）感染診断試薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、（1,3）-β-D-グルカン検出（G実験）試薬、ガラクトマンナンテスト（GM実験）試薬など、用途別には、病院、研究室、その他などにセグメント区分してまとめました。侵襲性真菌症（IFD）感染診断試薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・侵襲性真菌症（IFD）感染診断試薬の世界市場概要（サマリー） ・侵襲性真菌症（IFD）感染診断試薬の企業別販売量・売上 ・侵襲性真菌症（IFD）感染診断試薬の企業別市場シェア ・侵襲性真菌症（IFD）感染診断試薬の世界市場規模 2016年-2021年：種類別（（1,3）-β-D-グルカン検出（G実験）試薬、ガラクトマンナンテスト（GM実験）試薬） ・侵襲性真菌症（IFD）感染診断試薬の世界市場規模 2016年-2021年：用途別（病院、研究室、その他） ・侵襲性真菌症（IFD）感染診断試薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・侵襲性真菌症（IFD）感染診断試薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Invasive Fungal Disease (IFD) Infection Diagnostic Reagent will have significant change from previous year. By the most conservative estimates of global Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Invasive Fungal Disease (IFD) Infection Diagnostic Reagent market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market...
  • 世界の在宅酸素療法（HOT）装置市場予測 2021年-2026年
    LPI21MY9225 / LP Information / 2021年5月 / LPインフォメーション社の「在宅酸素療法（HOT）装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、酸素源装置、酸素供給装置など、用途別には、慢性閉塞性肺疾患（COPD）、喘息、閉塞性睡眠時無呼吸、呼吸窮迫症候群（RDS）、嚢胞性線維症、肺炎などにセグメント区分してまとめました。在宅酸素療法（HOT）装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・在宅酸素療法（HOT）装置の世界市場概要（サマリー） ・在宅酸素療法（HOT）装置の企業別販売量・売上 ・在宅酸素療法（HOT）装置の企業別市場シェア ・在宅酸素療法（HOT）装置の世界市場規模 2016年-2021年：種類別（酸素源装置、酸素供給装置） ・在宅酸素療法（HOT）装置の世界市場規模 2016年-2021年：用途別（慢性閉塞性肺疾患（COPD）、喘息、閉塞性睡眠時無呼吸、呼吸窮迫症候群（RDS）、嚢胞性線維症、肺炎） ・在宅酸素療法（HOT）装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・在宅酸素療法（HOT）装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Home Oxygen Therapy Devices will have significant change from previous year. By the most conservative estimates of global Home Oxygen Therapy Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Home Oxygen Therapy Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Home Oxygen Therapy Devices...

    • ◆H&Iグローバルリサーチのお客様（例）◆